ESC 2025: β-blockers after myocardial infarction with mildly reduced ejection fraction

📚 ESC 2025 Coverage: The SMuRF-less Illusion: Inflammation Unmasks Hidden Cardiovascular Risk in Healthy Women, by Dr. Hafezi, Cardiovascular Specialist....

📚 ESC 2025 Coverage: A Classic Revived: Digitoxin Lowers Risk in HFrEF When Added to Modern Therapy, by Dr. Talasaz, Clinical Pharmacist....

Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy...

📚 ESC 2025 Coverage: All at Once or One Step at a Time? Immediate Revascularisation Falls Short of Non-Inferiority in STEMI Patients, by Dr. Soltani Moghadam, Cardiovascular Researcher....

📚 ESC 2025 Coverage: Finding the Silent Beat: Remote ECG Screening Slightly Boosts Atrial Fibrillation Detection, by Dr. Tahmtan, Fellowship of Electrophysiology....

📚 ESC 2025 Coverage: Cholesterol Crushed, But Grafts Still Failed: Evolocumab Misses the Mark in NEWTON-CABG, by Dr. Ghavidel, Cardiovascular Surgeon....

📚 ESC 2025 Coverage: More Isn’t Always Better: Dual Antiplatelet Therapy Falls Short After CABG for ACS, by Dr. Mehrpouya, Interventional Cardiologist....

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrumVICTORIA and VICTOR Clinical Trials📚 ESC 2025 Coverage: Bridging Stability and Severity: Vericiguat’s ...

Reduction of Antihypertensive Treatment in Nursing Home Residents📚 ESC 2025 Coverage: Taking the Pressure Off, Gently: Can Fewer BP Pills Help Frail Elders Thrive? by Dr. Mansouri, Internal Medicine ...